Ullman Weighs In on FDA Warnings and the Delta-8 THC Market

May 16, 2022 | Cannabis

Ullman was cited in the Natural Products Insider article “Lawyers skeptical FDA warning letters will chill delta-8 THC market.”

The article discusses the effect of the recent rash of FDA warning letters on delta-8 THC products. The warning letters note that delta-8 THC is not an approved treatment for medical conditions.

Asked whether the warning letters will chill the delta-8 THC market, Marc responded, “Zero. Not at all.” That is because the FDA hasn’t followed up with a court action against companies that mislabel the products as having a therapeutic use.

Read the full article here

Share this article:
  • Marc S. Ullman

Related News

Get legal updates and news delivered to your inbox